- Johnson & Johnson pauses COVID-19 vaccine trials
- Impasse in U.S. fiscal aid package talks sours sentiment
- Lower oil prices hurt Australian energy stocks
(Updates to close)
Australian shares closed lower on Wednesday, with heavy selling in financial and energy stocks, as halted COVID-19 vaccine trials and an elusive U.S. coronavirus relief package dented risk appetite.
The S&P/ASX 200 index (xjo) slipped 0.3% to 6,179.20 at the close of trade. The benchmark closed 1% higher on Tuesday.
Global markets took cue as major indexes on Wall Street closed the previous session in the red, after COVID-19 vaccine trials were paused by Johnson & Johnson JNJ.N due to an unexplained illness in a study participant.
Diminishing hopes for the passage of a U.S. coronavirus relief bill also added to the gloom after House Speaker Nancy Pelosi rejected the $1.8 trillion proposal from the White House.
"It's (U.S. stimulus) become a fairly politically charged event, and I'm not sure that the Democrats are going to give Mr. Trump a free kick and pass anything stimulus wise for the next 20 days," said Damian Rooney, director of equity sales at Argonaut.
The heavyweight financial sector .AXFJ stocks finished about 1% lower, with the so-called "Big Four" banks closing in the red.
"Few brokers are starting to look at the banking sector after its big run, so I think there's a few profit takers there," Henry Jennings, a senior analyst and portfolio manager at Marcustoday said.
Energy stocks .AXEJ slid 0.9% at close, after oil prices slipped, with Woodside Petroleum (WPL) easing 1.2% and Oil Search losing 1.7%.
Limiting losses, the healthcare sector .AXHJ advanced 1.3%, with the help of CSL Ltd's (CSL) 1.4% gain and Sonic Healthcare (SHL) closing 2.3% firmer.
CSL lifted its FY2021 net profit to be between $2.17 bln and $2.27 bln at constant currency, compared with its initial forecast of $2.10 bln to $2.27 bln
Meanwhile, Sonic Healthcare marked its highest close after reporting first-quarter core earnings of A$580 million, up from A$340 million last year.
In New Zealand, the benchmark S&P/NZX 50 index (nz50) rose 0.72% to yet another closing high of 12,543.61.
Top gainers were Mainfreight Ltd (MFT) , up 5.77%, followed by EBOS Group Ltd (EBO) , gaining 3.46%.
- Forums
- ASX - By Stock
- News: WOR Australia shares drop as vaccine trials halt, stimulus hopes fade
WOR
worley limited
Add to My Watchlist
0.23%
!
$13.13

Johnson & Johnson pauses COVID-19 vaccine trials Impasse in U.S....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.13 |
Change
0.030(0.23%) |
Mkt cap ! $6.775B |
Open | High | Low | Value | Volume |
$13.13 | $13.19 | $13.02 | $22.70M | 1.728M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30 | $13.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 9668 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 13.080 |
1 | 1533 | 13.050 |
1 | 38000 | 13.000 |
1 | 1200 | 12.970 |
2 | 2671 | 12.950 |
Price($) | Vol. | No. |
---|---|---|
13.200 | 5755 | 2 |
13.230 | 1000 | 1 |
13.240 | 3271 | 2 |
13.250 | 750 | 1 |
13.260 | 2500 | 1 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
WOR (ASX) Chart |